Changing from preserved, to preservative-free cyclosporine 0.1% enhanced triple glaucoma therapy: impact on ocular surface disease-a randomized controlled trial.
Anastasios-Georgios KonstasKonstadinos G BoboridisGeorgios P AthanasopoulosAnna-Bettina HaidichIrini C VoudouragkakiEirini PagkalidouAndreas KatsanosL Jay KatzPublished in: Eye (London, England) (2023)
Changing from preserved to PF glaucoma medications improves ocular surface health and IOP control. Topical cyclosporine 0.1% further reverses GTR-OSD.